ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022
July 19, 2022 08:30 ET
|
ProPhase Labs, Inc.
Garden City, NY, July 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that it will host a live webcast on Thursday,...
ProPhase Labs Announces Significant Laboratory Expansion
June 13, 2022 08:30 ET
|
ProPhase Labs, Inc.
Expanding in-house clinical testing capabilities Initiates plans to build new genomics laboratory Garden City, NY, June 13, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a...
ProPhase Labs Announces Record First Quarter 2022 Financial Results
May 13, 2022 08:30 ET
|
ProPhase Labs, Inc.
Record Net Revenues of $47.5 Million, Up 211% Year-over-Year Record Net Income of $12.5 Million, Increasing 1082% Year-over-Year Announces Special Cash Dividend of $0.30 per...
ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor Conference
May 11, 2022 18:25 ET
|
ProPhase Labs, Inc.
Garden City, NY, May 11, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present at...
ProPhase Labs Announces Appointment of Bill White as Chief Financial Officer
May 10, 2022 08:15 ET
|
ProPhase Labs, Inc.
Garden City, NY, May 10, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified diagnostics and genomics company, announced today that Bill White has been appointed Chief...
ProPhase Labs to Host First Quarter 2022 Financial Results Conference Call on Friday, May 13, 2022 at 11:00 a.m. Eastern Time
May 06, 2022 16:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, May 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, will hold a conference call on Friday, May 13, 2022 at 11:00...
ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022
April 27, 2022 08:15 ET
|
ProPhase Labs, Inc.
Garden City, NY, April 27, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present...
ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
March 30, 2022 08:30 ET
|
ProPhase Labs, Inc.
Record Financial Results also expected for Q1 2022 Company to hold a conference call March 30, 2022, at 11:00AM ET Garden City, NY, March 30, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs,...
ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 2022 at 11:00 a.m. Eastern Time
March 24, 2022 08:15 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, March 24, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified company offering a range of services including diagnostic testing, genomics testing and contract...
ProPhase Labs Announces Special Cash Dividend
February 16, 2022 08:15 ET
|
ProPhase Labs, Inc.
Anticipates Record Q4 2021 and Q1 2022 Revenues and Profits Garden City, NY, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company,...